EUROAPOTHECA, UAB
JAR Code: 300854822
ActiveFinancial Reports
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue | 1 030 355 000 | 1 596 133 000 | 1 658 310 000 | 573 371 000 | |
| Profit Before Tax | 35 468 000 | 30 344 000 | −16 933 000 | 22 346 000 | |
| Net Profit | 26 366 000 | 25 844 000 | −20 808 000 | −20 789 000 | |
| Profit margin | 2.6% | 1.6% | -1.3% | -3.6% | |
| Equity | 585 366 000 | 566 929 000 | 518 118 000 | 497 246 000 | |
| Liabilities | 554 083 000 | 569 093 000 | 568 901 000 | 321 904 000 | |
| Total Assets | 1 139 449 000 | 1 136 022 000 | 1 087 019 000 | 436 722 000 |
Financial Reports
2025
Balance Sheet
Total Assets436 722 000 €
Long-term Assets271 638 000 €
Short-term Assets165 084 000 €
Equity497 246 000 €
Liabilities321 904 000 €
Profit & Loss Statement
Revenue573 371 000 €
Profit Before Tax22 346 000 €
Net Profit−20 789 000 €
2024
Balance Sheet
Total Assets1 087 019 000 €
Long-term Assets750 441 000 €
Short-term Assets336 578 000 €
Equity518 118 000 €
Liabilities568 901 000 €
Profit & Loss Statement
Revenue1 658 310 000 €
Profit Before Tax−16 933 000 €
Net Profit−20 808 000 €
2023
Balance Sheet
Total Assets1 136 022 000 €
Long-term Assets820 075 000 €
Short-term Assets315 947 000 €
Equity566 929 000 €
Liabilities569 093 000 €
Profit & Loss Statement
Revenue1 596 133 000 €
Profit Before Tax30 344 000 €
Net Profit25 844 000 €
2022
Balance Sheet
Total Assets1 139 449 000 €
Long-term Assets799 197 000 €
Short-term Assets340 252 000 €
Equity585 366 000 €
Liabilities554 083 000 €
Profit & Loss Statement
Revenue1 030 355 000 €
Profit Before Tax35 468 000 €
Net Profit26 366 000 €
2021
Balance Sheet
Total Assets457 805 000 €
Long-term Assets454 831 000 €
Short-term Assets2 974 000 €
Equity375 732 000 €
Liabilities—
Profit & Loss Statement
Revenue5 948 000 €
Profit Before Tax3 558 000 €
Net Profit—
2020
Balance Sheet
Total Assets490 477 000 €
Long-term Assets475 700 000 €
Short-term Assets14 777 000 €
Equity383 453 000 €
Liabilities—
Profit & Loss Statement
Revenue4 947 000 €
Profit Before Tax29 983 000 €
Net Profit—
2019
Balance Sheet
Total Assets496 767 000 €
Long-term Assets483 104 000 €
Short-term Assets13 663 000 €
Equity375 404 000 €
Liabilities—
Profit & Loss Statement
Revenue6 459 000 €
Profit Before Tax10 700 000 €
Net Profit—
2018
Balance Sheet
Total Assets501 925 000 €
Long-term Assets486 756 000 €
Short-term Assets15 169 000 €
Equity365 196 000 €
Liabilities—
Profit & Loss Statement
Revenue4 919 000 €
Profit Before Tax2 174 000 €
Net Profit—
2017
Balance Sheet
Total Assets241 266 000 €
Long-term Assets231 192 000 €
Short-term Assets10 074 000 €
Equity197 764 000 €
Liabilities—
Profit & Loss Statement
Revenue3 425 000 €
Profit Before Tax72 997 000 €
Net Profit—
2016
Balance Sheet
Total Assets194 973 000 €
Long-term Assets178 135 000 €
Short-term Assets16 838 000 €
Equity147 070 000 €
Liabilities—
Profit & Loss Statement
Revenue3 193 000 €
Profit Before Tax21 001 000 €
Net Profit—
2014
Balance Sheet
Total Assets153 889 018 €
Long-term Assets146 965 651 €
Short-term Assets6 923 367 €
Equity133 361 040 €
Liabilities20 527 977 €
Profit & Loss Statement
Revenue2 451 923 €
Profit Before Tax17 469 880 €
Net Profit17 475 672 €
Source: Registrų centras